Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Heidi Fields currently holds 17,500 shares of Phathom Pharmaceuticals, Inc. (PHAT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Heidi Fields has been a net seller of PHAT stock. They have purchased $65.3K and sold $7.8M worth of shares.
Heidi Fields's most recent insider trade was on May 23, 2024, when they sold 17,500 shares at $0.00 per share.
Heidi Fields serves as Executive at Phathom Pharmaceuticals, Inc. (PHAT). They have executed 85 insider transactions totaling $7.9M over their tenure at the company.
Heidi Fields holds the position of Executive at Phathom Pharmaceuticals, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 16 years and currently hold a stake valued at $0.
Heidi Fields has shown a selling trading pattern, with $65.3K in total purchases and $7.8M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Heidi Fields was on Jul 19, 2018, when they sold $958.0K worth of FNGN shares. This transaction involved 21,290 shares at $45.00 per share.
Heidi Fields currently owns 17,500 shares of Phathom Pharmaceuticals, Inc. (PHAT), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Heidi Fields's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Heidi Fields has 85 Form 4 filings on record as an insider at Phathom Pharmaceuticals, Inc..
Set alerts for Heidi Fields and 40,000+ other insiders.